Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 63

1.

Effectiveness and adverse effects of hormonal therapy for prostate cancer: Japanese experience and perspective.

Namiki M, Ueno S, Kitagawa Y, Fukagai T, Akaza H.

Asian J Androl. 2012 May;14(3):451-7. doi: 10.1038/aja.2011.121. Epub 2012 Mar 26. Review.

PMID:
22447200
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Locally advanced prostate cancer: effective treatments, but many adverse effects.

[No authors listed]

Prescrire Int. 2013 Jan;22(134):18-20, 22-3. Review.

PMID:
23367679
[PubMed - indexed for MEDLINE]
3.

Medical therapy of prostate cancer. A review.

Roscigno M, Sangalli M, Mazzoccoli B, Scattoni V, Da Pozzo L, Rigatti P.

Minerva Urol Nefrol. 2005 Jun;57(2):71-84. Review.

PMID:
15951731
[PubMed - indexed for MEDLINE]
4.

Endocrine treatment of prostate cancer.

Tammela T.

J Steroid Biochem Mol Biol. 2004 Nov;92(4):287-95. Epub 2004 Dec 31. Review.

PMID:
15663992
[PubMed - indexed for MEDLINE]
5.

Contemporary role of androgen deprivation therapy for prostate cancer.

Pagliarulo V, Bracarda S, Eisenberger MA, Mottet N, Schröder FH, Sternberg CN, Studer UE.

Eur Urol. 2012 Jan;61(1):11-25. doi: 10.1016/j.eururo.2011.08.026. Epub 2011 Aug 19. Review.

PMID:
21871711
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

[Androgen-deprivation therapy in prostate cancer: clinical evidence and future perspectives].

Pinto F, Calarco A, Totaro A, Sacco E, Volpe A, Racioppi M, D'Addessi A, Bassi PF.

Urologia. 2010 Apr-May;77(2):71-83. Review. Italian.

PMID:
20890863
[PubMed - indexed for MEDLINE]
7.

Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.

Kumar S, Shelley M, Harrison C, Coles B, Wilt TJ, Mason MD.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006019. Review.

PMID:
17054269
[PubMed - indexed for MEDLINE]
8.

Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.

Nair B, Wilt T, MacDonald R, Rutks I.

Cochrane Database Syst Rev. 2002;(1):CD003506. Review.

PMID:
11869665
[PubMed - indexed for MEDLINE]
9.
10.
11.

Management strategies for locally advanced prostate cancer.

Jani AB.

Drugs Aging. 2006;23(2):119-29. Review.

PMID:
16536635
[PubMed - indexed for MEDLINE]
12.

Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.

Seidenfeld J, Samson DJ, Aronson N, Albertson PC, Bayoumi AM, Bennett C, Brown A, Garber A, Gere M, Hasselblad V, Wilt T, Ziegler K.

Evid Rep Technol Assess (Summ). 1999 May;(4):i-x, 1-246, I1-36, passim. Review.

PMID:
11098244
[PubMed - indexed for MEDLINE]
Free Article
13.

[Neoadjuvant therapy of prostate carcinoma].

Ebert T.

Praxis (Bern 1994). 1997 Nov 12;86(46):1815-8. Review. German.

PMID:
9454282
[PubMed - indexed for MEDLINE]
14.

Neoadjuvant total androgen suppression and radiotherapy in the management of locally advanced prostate cancer.

Roach M 3rd.

Semin Urol Oncol. 1996 May;14(2 Suppl 2):32-7; discussion 38. Review.

PMID:
8725889
[PubMed - indexed for MEDLINE]
15.

[Prostate cancer].

Uchida K, Akaza H.

Gan To Kagaku Ryoho. 1999 Jan;26(1):76-82. Review. Japanese.

PMID:
9987501
[PubMed - indexed for MEDLINE]
16.

External beam radiation therapy for clinically localized prostate cancer: when and how we optimize with concurrent hormonal deprivation.

Koontz BF, Lee WR.

Arch Esp Urol. 2011 Oct;64(8):858-64. Review. English, Spanish.

PMID:
22052767
[PubMed - indexed for MEDLINE]
17.

Hormonal therapy.

Namiki M, Ueno S, Kitagawa Y, Konaka H, Mizokami A, Koh E, Fukagai T.

Int J Clin Oncol. 2007 Dec;12(6):427-32. Epub 2007 Dec 21. Review.

PMID:
18071861
[PubMed - indexed for MEDLINE]
18.

[New development of endocrine therapy in prostate cancer].

Naito S.

Gan To Kagaku Ryoho. 1996 May;23(6):684-8. Review. Japanese.

PMID:
8645018
[PubMed - indexed for MEDLINE]
19.

Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments.

Payne H, Mason M.

Br J Cancer. 2011 Nov 22;105(11):1628-34. doi: 10.1038/bjc.2011.385. Epub 2011 Oct 18. Review.

PMID:
22009028
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing surgical treatment for prostate cancer.

Gomella LG, Zeltser I, Valicenti RK.

Urology. 2003 Dec 29;62 Suppl 1:46-54. Review.

PMID:
14747041
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk